Horizon Therapeutics Public Ltd Co

Calamos Advisors LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/26/2023

Shares

100,000

Value ($000)

11,569

Weight

0.1%

2019 Q4 - 2023 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/26/2023	11,569	0.1%	100,000	9/30/2023
2023 Q2	7/28/2023	23,501	0.1%	228,495	6/30/2023
2023 Q1	5/4/2023	24,938	0.1%	228,495	3/31/2023
2022 Q4	1/26/2023	6,436	0.0%	56,558	12/31/2022
2021 Q4	2/1/2022	6,096	0.0%	56,567	12/31/2021
2021 Q3	10/26/2021	8,699	0.0%	79,416	9/30/2021
2021 Q2	7/22/2021	5,026	0.0%	53,678	6/30/2021
2021 Q1	4/12/2021	1,759	0.0%	19,114	3/31/2021
2020 Q4	1/27/2021	1,450	0.0%	19,826	12/31/2020
2020 Q3	10/26/2020	1,379	0.0%	17,751	9/30/2020
2020 Q2	7/27/2020	651	0.0%	11,713	6/30/2020
2019 Q4	1/15/2020	485	0.0%	13,400	12/31/2019